TherapeuticsMD Inc (NASDAQ:TXMD)

Delayed Data
As of Feb 22
 -0.10 / -1.96%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for TherapeuticsMD Inc have a median target of 10.00, with a high estimate of 28.00 and a low estimate of 6.00. The median estimate represents a +99.60% increase from the last price of 5.01.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in TherapeuticsMD Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 08

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -21.57%
Growthannually 21.80%


Growthquarterly 5.54%
Growthannually -9.16%
Key to the earnings and sales forecast charts.